Tilray
Tilray, Inc. is a company engaged in the research, cultivation, processing, and distribution of medical cannabis. It provides pharmaceutical-grade cannabis products to a diverse clientele, including patients, physicians, pharmacies, governments, and researchers, while also supporting clinical research applications. The company is involved in the cannabis-lifestyle sector, offering hemp-based foods and craft beverages, emphasizing the delivery of safe and reliable medical cannabis products. Tilray operates across multiple countries, including Argentina, Australia, Canada, Germany, Israel, and the United Kingdom, among others. Incorporated in 2018, Tilray is headquartered in Nanaimo, Canada.
Truss Beverages
Acquisition in 2024
Truss Beverages is a licensed producer of cannabis-infused beverages in Canada, focusing on innovation within the non-alcoholic drink sector. Established to meet the growing demand for cannabis products, the company offers a diverse range of beverages, including fruity, crisp, and citrus-flavored options, all crafted without added sugar. Truss Beverages aims to provide consumers with a variety of infused drinks that cater to different tastes and preferences, contributing to the evolving landscape of cannabis consumption in Canada.
HEXO Corp is a consumer packaged goods cannabis company that develops and distributes award-winning products for the global cannabis market. Utilizing a hub and spoke business strategy, HEXO partners with Fortune 500 companies to leverage its brand value, cannabinoid isolation technology, and regulatory expertise, enhancing the distribution capabilities of established firms. As one of the largest licensed cannabis companies in Canada, HEXO operates 1.8 million square feet of facilities in Ontario and Quebec, and is establishing a processing, production, and distribution center in Greece to expand its European presence. The company serves both the adult-use and medical cannabis markets in Canada.
HEXO Corp is a consumer packaged goods cannabis company that develops and distributes award-winning products for the global cannabis market. Utilizing a hub and spoke business strategy, HEXO partners with Fortune 500 companies to leverage its brand value, cannabinoid isolation technology, and regulatory expertise, enhancing the distribution capabilities of established firms. As one of the largest licensed cannabis companies in Canada, HEXO operates 1.8 million square feet of facilities in Ontario and Quebec, and is establishing a processing, production, and distribution center in Greece to expand its European presence. The company serves both the adult-use and medical cannabis markets in Canada.
MedMen is a cannabis industry pioneer, operating licensed facilities for cultivation, manufacturing, and retail. Based in Culver City, California, the company supports sensible drug laws and offers turnkey services to license holders, bringing institutional best practices to the industry. Through MedMen Capital, it strategically invests in key markets across the U.S. and Canada, guiding investors in this rapidly growing sector.
Aphria
Acquisition in 2020
Aphria is a Canadian company based in Leamington that manufactures medicinal cannabis products. With over seven decades of greenhouse growing experience, Aphria has developed integrated solutions for high-quality cannabis production. The company specializes in producing oils derived from various strains including Sativa-hybrid, Indica, and hybrid plants. Aphria is well-positioned to be a leader in the medical marijuana industry, leveraging its expertise under Health Canada’s Marijuana for Medical Purposes Regulations.
Privateer Holdings
Acquisition in 2019
Privateer Holdings, Inc. is a private equity firm based in Seattle, Washington, established in 2010. The company focuses on investments in the legal cannabis industry, aiming to shape its future through acquisitions, investments, and incubation of cannabis-related businesses. With additional offices in San Francisco, Newport Beach, and Denver, Privateer seeks to build a portfolio of global brands that will lead and legitimize the cannabis market. Its notable investments include Leafly, a prominent cannabis information resource; Tilray, a leading producer of medical cannabis; and Marley Natural, the official cannabis and lifestyle brand associated with Bob Marley. Through its strategic initiatives, Privateer aims to contribute to the end of cannabis prohibition and mitigate the associated social harms.
FOUR20
Acquisition in 2019
FOUR20 is a cannabis retail brand operating six locations in Alberta, Canada, and is focused on enhancing the adult-use cannabis retail experience. The brand is led by experts in the retail and cannabis industries and aims to foster community engagement, promote a positive cannabis culture, and set high standards for retail practices in Canada. FOUR20 prioritizes social responsibility, serving as a resource for municipalities and organizations to ensure that cannabis culture is advocated in a responsible manner. The company emphasizes providing consumers with high-quality products, reliable information, and exceptional customer service to support informed choices in their cannabis experiences.
Natura Naturals
Acquisition in 2019
Natura Naturals Inc. is a Canadian company based in Leamington that specializes in the cultivation of cannabis for medical purposes. It is licensed to grow cannabis and operates a large greenhouse facility exceeding 700,000 square feet, designed to create optimal growing conditions. The company provides medical cannabis to doctors and patients as part of their treatment regimens, ensuring that its products meet regulatory standards for medicinal use. As a subsidiary of MCM Acres Ltd., Natura Naturals is positioned to support various medical applications through its hydroponic cultivation methods.
Alef Biotechnology
Acquisition in 2018
Alef Biotechnology is a licensed producer of medical cannabis in Chile, dedicated to the research and development of cannabinoid products aimed at treating various medical conditions. The company focuses on enhancing the quality of life for individuals experiencing pain by creating innovative drugs and novel drug delivery systems. In addition to its manufacturing capabilities, Alef Biotechnology serves as an exporter of medical cannabis products, contributing to the advancement of therapeutic solutions in the medical cannabis sector.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at
support@teaserclub.com. Your feedback is most welcome.